Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial - PARIS

Description:

PARIS was a randomized, single-center, double-blind, placebo-controlled trial designed to study whether the angiotensin-converting enzyme (ACE) inhibitor quinapril would reduce restenosis after coronary stenting in patients homozygous for the deletion allele of the ACE gene polymorphism (DD).